| reference | Luduena, R.F., et al., Tubulin structure and biochemistry. Curr. Opin. Cell Biol. 4, 53-57, (1992) Abstract |
| | Jordan, A., et al., Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev. 18, 259-296, (1998) Abstract |
| | Andreu, J.M., et al., Role of the colchicine ring A and its methoxy groups in the binding to tubulin and microtubule inhibition. Biochemistry 37, 8356-8368, (1998) Abstract |
| | Banerjee, A., Differential effects of colchicine and its B-ring modified analog MTPT on the assembly-independent GTPase activity of purified β-tubulin isoforms from bovine brain. Biochem. Biophys. Res. Commun. 231, 698, (1997) Abstract |
| | Suzuki, Y, Cell death, phagocytosis, and neurogenesis in mouse olfactory epithelium and vomeronasal organ after colchicine treatment. Ann. N.Y. Acad. Sci. 30, 252-254, (1998) |
| | DeVincenzo, R., et al., Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines. Anticancer Drug Des. 13, 19-33, (1998) Abstract |
| | Ceccatelli, S., et al., Apoptosis in rat hippocampal dentate gyrus after intraventricular colchicine. Neuroreport 8, 3779-3783, (1997) Abstract |
| | Want, T.H., et al., Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273, 4928-4936, (1998) Abstract |
| Merck | Merck 13,2496 |
| Beilstein | Beil. 14,IV,946 |
| | Aldrich MSDS 1, 482:D / Corp MSDS 1 (1), 903:B / FT-IR 1 (2), 361:C / FT-IR 2 (2), 2980:D / FT-NMR 1 (2), 1374:C / IR-Spectra (3), 1072:F / IR-Spectra (2), 938:B / NMR-Reference 2 (2), 340:A / RegBook 1 (2), 2007:C / Sigma FT-IR 1 (2), 403:C / Structure Index 1, 320:D:5 |
